Persistency of response to omalizumab therapy in severe allergic (IgE‐mediated) asthma

To cite this article: Bousquet J, Siergiejko Z, Świebocka E, Humbert M, Rabe KF, Smith N, Leo J, Peckitt C, Maykut R, Peachey G. Persistency of response to omalizumab therapy in severe allergic (IgE‐mediated) asthma. Allergy 2011; 66: 671–678.

[1]  D. MacGlashan,et al.  Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge. , 2009, The Journal of allergy and clinical immunology.

[2]  U. Wahn,et al.  Relationship between pretreatment specific IgE and the response to omalizumab therapy , 2009, Allergy.

[3]  L. Cardell,et al.  The size of the disease relevant IgE antibody fraction in relation to ‘total‐IgE’ predicts the efficacy of anti‐IgE (Xolair®) treatment , 2009, Allergy.

[4]  S. Holgate,et al.  Safety and tolerability of omalizumab , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  K. Chung,et al.  Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study. , 2008, Respiratory medicine.

[6]  How to evaluate a patient's response to anti-IgE , 2007, European Respiratory Review.

[7]  J. Bousquet,et al.  Predicting and evaluating response to omalizumab in patients with severe allergic asthma. , 2007, Respiratory medicine.

[8]  J. Bousquet,et al.  The effect of treatment with omalizumab, an anti‐IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma , 2005, Allergy.

[9]  J Bousquet,et al.  Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE , 2005, Allergy.

[10]  A. Togias,et al.  Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. , 1997, Journal of immunology.

[11]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .